EMEA-000551-PIP04-21-M02 - paediatric investigation plan

Givinostat
PIPHuman

Key facts

Active Substance
Givinostat
Therapeutic area
Neurology
Decision number
P/0240/2023
PIP number
EMEA-000551-PIP04-21-M02
Pharmaceutical form(s)
Oral suspension
Condition(s) / indication(s)
Treatment of Duchenne muscular dystrophy
Route(s) of administration
Oral use
Contact for public enquiries

Italfarmaco S.p.A.

E-mail: ITFPIP@italfarmacogroup.com
Tel: +39 0264432500

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page